BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

GANYMED Pharmaceuticals AG 

Freiligrathstrasse 12

Mainz    D-55131  Germany
Phone: 49-0-6131-1440-10 Fax: 49-0-6131-1440-111


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
GANYMED Pharmaceuticals AG's IMAB027 Enters Phase I/II Clinical Trial For Ovarian Cancer 2/12/2014 8:59:37 AM    More...
GANYMED Pharmaceuticals AG To Present At The 32nd Annual J.P. Morgan Healthcare Conference 12/19/2013 9:35:30 AM    More...
GANYMED Pharmaceuticals AG Scrounges Up $60 Million Financing Round 11/18/2013 8:59:58 AM    More...
GANYMED Pharmaceuticals AG's IMAB362 Receives Orphan Drug Designation From FDA and European Medicines Agency for Pancreatic Cancer 10/21/2013 8:58:29 AM    More...
GANYMED Pharmaceuticals AG Announces CE Marking for Test to Assess Claudin-18.2 Expression in Solid Tumors 9/11/2013 8:17:50 AM    More...
GANYMED Pharmaceuticals AG Release: Clinical Phase I Results of GANYMED's iMAB362 Antibody Demonstrate Excellent Safety 8/4/2010 10:57:56 AM    More...
GANYMED Pharmaceuticals AG Closes EUR 65 M Financing Round 11/18/2008 6:29:42 AM    More...
ATS Acquires Majority Shareholding in GANYMED Pharmaceuticals AG 8/21/2008 7:07:06 AM    More...
Selexis SA Signs Commercial License Agreement With GANYMED Pharmaceuticals AG 7/11/2007 9:25:29 AM    More...
GANYMED Pharmaceuticals AG Raises Euro 33.7 Million in Series C Financing Round 4/18/2007 10:47:50 AM    More...
12

//-->